• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients.

作者信息

Franchini Massimo, Casadevall Arturo, Senefeld Jonathon W, Joyner Michael J, Sullivan David J, Focosi Daniele

机构信息

Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantova, Italy.

Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

出版信息

Semin Thromb Hemost. 2024 Jun;50(4):648-653. doi: 10.1055/s-0043-1776876. Epub 2023 Nov 20.

DOI:10.1055/s-0043-1776876
PMID:37984358
Abstract
摘要

相似文献

1
Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients.关于使用新冠康复者血浆治疗免疫功能低下患者的建议。
Semin Thromb Hemost. 2024 Jun;50(4):648-653. doi: 10.1055/s-0043-1776876. Epub 2023 Nov 20.
2
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19.免疫抑制患者 COVID-19 的门诊治疗与疫苗加强恢复期血浆治疗。
mBio. 2024 May 8;15(5):e0040024. doi: 10.1128/mbio.00400-24. Epub 2024 Apr 11.
3
Convalescent blood plasma (CBP) donated by recovered COVID-19 patients - A comment.关于新冠康复患者捐献的恢复期血浆（CBP）的评论
Transfus Apher Sci. 2021 Jun;60(3):103108. doi: 10.1016/j.transci.2021.103108. Epub 2021 Mar 2.
4
[COVID-19: Still a place for the convalescent plasma? Focus on the immunocompromised patients].[新型冠状病毒肺炎：恢复期血浆疗法仍有应用空间？聚焦免疫功能低下患者]
Rev Med Interne. 2023 Sep;44(9):467-471. doi: 10.1016/j.revmed.2023.08.005. Epub 2023 Sep 7.
5
Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations.恢复期血浆在免疫功能低下和脆弱人群中预防和治疗 SARS-CoV-2 的潜在用途。
Expert Rev Vaccines. 2022 Jul;21(7):877-884. doi: 10.1080/14760584.2021.1932475. Epub 2021 May 27.
6
Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.免疫功能低下宿主接受恢复期血浆治疗后出现多种 SARS-CoV-2 抗体逃逸变异体。
mSphere. 2021 Aug 25;6(4):e0048021. doi: 10.1128/mSphere.00480-21.
7
Treatment of immunocompromised COVID-19 patients with convalescent plasma.免疫抑制的 COVID-19 患者使用恢复期血浆治疗。
Transpl Infect Dis. 2021 Apr;23(2):e13477. doi: 10.1111/tid.13477. Epub 2020 Nov 29.
8
Treatment of chronic COVID-19 with convalescent/postvaccination plasma in patients with hematologic malignancies.在血液系统恶性肿瘤患者中使用恢复期/疫苗接种后血浆治疗慢性 COVID-19。
Int J Cancer. 2024 Aug 15;155(4):618-626. doi: 10.1002/ijc.34988. Epub 2024 May 9.
9
Thinking more about therapy with convalescent plasma for COVID-19 patients.更多地思考针对新冠病毒肺炎患者使用康复期血浆进行治疗的问题。
Hum Vaccin Immunother. 2020 Nov 1;16(11):2601-2603. doi: 10.1080/21645515.2020.1787073. Epub 2020 Jul 9.
10
Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products.用恢复期血浆和基于血浆的产品治疗 B 细胞耗竭的 COVID-19 患者。
Clin Immunol. 2021 Jun;227:108723. doi: 10.1016/j.clim.2021.108723. Epub 2021 Apr 7.

引用本文的文献

1
Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report.静脉注射免疫球蛋白治疗免疫功能低下患者的持续性 COVID-19：简要报告。
Front Immunol. 2024 Apr 19;15:1399180. doi: 10.3389/fimmu.2024.1399180. eCollection 2024.
2
Factors associated with the SARS-CoV-2 immunoglobulin-G titer levels in convalescent whole-blood donors: a Chinese cross-sectional study.与恢复期全血供者中 SARS-CoV-2 免疫球蛋白-G 滴度相关的因素：一项中国的横断面研究。
Sci Rep. 2024 Mar 13;14(1):6072. doi: 10.1038/s41598-024-56462-y.
3
The Role of Convalescent Plasma in COVID-19: A Conclusive Post-Pandemic Review.
恢复期血浆在 COVID-19 中的作用：大流行后的结论性综述。
Life (Basel). 2023 Dec 11;13(12):2322. doi: 10.3390/life13122322.